Aviv Healthcare Properties 8-K 2012 FY Other Events

Exhibit 99.2

AVIV HEALTHCARE PROPERTIES LIMITED PARTNERSHIP AND SUBSIDIARIES

Notes to Consolidated Financial Statements (unaudited)

17. Condensed Consolidating Information

The REIT and certain of the Partnership’s direct and indirect wholly owned subsidiaries (the Unencumbered Subsidiary Guarantors and Encumbered Subsidiary Guarantors) fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to our Senior Notes issued in February 2011, April 2011, March 2012 and October 2013. The Senior Notes were issued by Aviv Healthcare Properties Limited Partnership and Aviv Healthcare Capital Corporation (the Issuers). Separate financial statements of the guarantors are not provided as the consolidating financial information contained herein provides a more meaningful disclosure to allow investors to determine the nature of the assets held by and the operations of the respective guarantor andnon-guarantor subsidiaries. Other wholly owned subsidiaries (Non-Guarantor Subsidiaries) that were not included among the Unencumbered Subsidiary Guarantors or Encumbered Subsidiary Guarantors were not obligated with respect to the Senior Notes. TheNon-Guarantor Subsidiaries are subject to mortgages. The following summarizes our condensed consolidating information as of June 30, 2013 and December 31, 2012 and for the three and six months ended June 30, 2013 and 2012:

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Balance Sheet

As of June 30, 2013

(unaudited)

	Issuers		Unencumbered Subsidiary Guarantors			Encumbered Subsidiary Guarantors			Non-Guarantor Subsidiaries		Eliminations			Consolidated
Assets
Net real estate investments	$	51,062	$	729,038,969		$	195,330,213		$	83,739,437	$	—		$	1,008,159,681
Cash and cash equivalents		15,800,963		(1,356,813	)		(39,192	)		614,751		—			15,019,709
Deferred financing costs, net		8,239,927		—			4,813,397			14,105		—			13,067,429
Other		13,510,727		54,968,199			14,323,021			3,829,384		—			86,631,331
Investment in and due from related parties, net		959,869,614		—			—			—		(959,869,614	)		—
Total assets	$	997,472,293	$	782,650,355		$	214,427,439		$	88,197,677	$	(959,869,614	)	$	1,122,878,150
Liabilities and equity
Secured notes payable and other debt	$	402,971,100	$	—		$	80,000,000		$	13,769,102	$	—		$	496,740,202
Due to related parties		—		—			—			—		—			—
Tenant security and escrow deposits		—		12,781,430			3,341,483			1,054,897		—			17,177,810
Accounts payable and accrued expenses		12,789,236		2,994,814			1,651,083			682,473		—			18,117,606
Other liabilities		317,740		8,235,281			895,294			—		—			9,448,315
Total liabilities		416,078,076		24,011,525			85,887,860			15,506,472		—			541,483,933
Total equity		581,394,217		758,638,830			128,539,579			72,691,205		(959,869,614	)		581,394,217
Total liabilities and equity	$	997,472,293	$	782,650,355		$	214,427,439		$	88,197,677	$	(959,869,614	)	$	1,122,878,150

1

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Balance Sheet

As of December 31, 2012

(unaudited)

	Issuers		Unencumbered Subsidiary Guarantors			Encumbered Subsidiary Guarantors			Non-Guarantor Subsidiaries		Eliminations			Consolidated
Assets
Net real estate investments	$	53,750	$	731,036,359		$	197,221,045		$	55,149,862	$	—		$	983,461,016
Cash and cash equivalents		16,869,495		(1,746,141	)		(68,241	)		479,260		—			15,534,373
Deferred financing costs, net		8,964,976		—			5,672,918			13,371		—			14,651,265
Other		15,737,837		50,372,586			14,120,937			3,308,680		—			83,540,040
Investment in and due from related parties, net		711,027,894		—			—			—		(711,027,894	)		—
Total assets	$	752,653,952	$	779,662,804		$	216,946,659		$	58,951,173	$	(711,027,894	)	$	1,097,186,694
Liabilities and equity
Secured notes payable and other debt	$	403,180,433		—		$	280,506,139		$	21,466,843	$	—		$	705,153,415
Due to related parties		7,542,333		—			5,912			—		—			7,548,245
Tenant security and escrow deposits		50,000		14,202,777			3,560,361			465,034		—			18,278,172
Accounts payable and accrued expenses		13,702,409		6,152,923			3,988,102			364,380		—			24,207,814
Other liabilities		7,677,280		9,090,462			4,729,809			—		—			21,497,551
Total liabilities		432,152,455		29,446,162			292,790,323			22,296,257		—			776,685,197
Total equity		320,501,497		750,216,642			(75,843,664	)		36,654,916		(711,027,894	)		320,501,497
Total liabilities and equity	$	752,653,952	$	779,662,804		$	216,946,659		$	58,951,173	$	(711,027,894	)	$	1,097,186,694

2

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Statement of Operations and Comprehensive Income

For the Three Months Ended June 30, 2013

(unaudited)

	Issuers			Unencumbered Subsidiary Guarantors		Encumbered Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Consolidated
Revenues
Rental income	$	—		$	24,730,853	$	7,274,076	$	1,869,018	$	—		$	33,873,947
Interest on secured loans and financing lease		295,684			714,301		72,490		—		—			1,082,475
Interest and other income		4,152			71,854		851		45		—			76,902
Total revenues		299,836			25,517,008		7,347,417		1,869,063		—			35,033,324
Expenses
Interest expense		8,007,895			—		1,176,384		198,357		—			9,382,636
Depreciation and amortization		1,344			6,185,776		1,452,775		459,426		—			8,099,321
General and administrative		928,363			53,389		2,513,488		47,126		—			3,542,366
Transaction costs		117,269			119,913		1,050		125,837		—			364,069
Reserve for uncollectible secured loan and other receivables		(9,594	)		—		25,168		—		—			15,574
Loss on sale of assets, net		—			224,824		—		—		—			224,824
Total expenses		9,045,277			6,583,902		5,168,865		830,746		—			21,628,790
(Loss) income from continuing operations		(8,745,441	)		18,933,106		2,178,552		1,038,317		—			13,404,534
Discontinued operations		—			—		—		—		—			—
Net (loss) income		(8,745,441	)		18,933,106		2,178,552		1,038,317		—			13,404,534
Equity in income (loss) of subsidiaries		22,149,975			—		—		—		(22,149,975	)		—
Net income (loss) allocable to units	$	13,404,534		$	18,933,106	$	2,178,552	$	1,038,317	$	(22,149,975	)	$	13,404,534

3

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Statement of Operations and Comprehensive Income

For the Three Months Ended June 30, 2012

(unaudited)

				Unencumbered Subsidiary		Encumbered Subsidiary			Non-Guarantor
	Issuers			Guarantors		Guarantors			Subsidiaries		Eliminations			Consolidated
Revenues
Rental income	$	—		$	23,596,837	$	7,407,842		$	409,642	$	—		$	31,414,321
Interest on secured loans and financing lease		525,462			723,676		88,054			—		—			1,337,192
Interest and other income		197			61,387		307			—		—			61,891
Total revenues		525,659			24,381,900		7,496,203			409,642		—			32,813,404
Expenses
Interest expense		8,015,063			—		4,680,010			138,704		—			12,833,777
Depreciation and amortization		—			5,272,540		1,393,553			113,356		—			6,779,449
General and administrative		1,270,940			136,469		2,187,504			8,628		—			3,603,541
Transaction costs		714,942			704,558		86,768			35,920		—			1,542,188
Loss on impairment of assets		—			3,679,657		—			—		—			3,679,657
Reserve for uncollectible secured loan and other receivables		3,374,637			1,659,016		45,139			280		—			5,079,072
Other expenses		—			—		100,088			—		—			100,088
Total expenses		13,375,582			11,452,240		8,493,062			296,888		—			33,617,772
(Loss) income from continuing operations		(12,849,923	)		12,929,660		(996,859	)		112,754		—			(804,368	)
Discontinued operations		—			112,210		—			4,304,757		—			4,416,967
Net (loss) income		(12,849,923	)		13,041,870		(996,859	)		4,417,511		—			3,612,599
Equity in income (loss) of subsidiaries		16,462,522			—		—			—		(16,462,522	)		—
Net income (loss) allocable to units	$	3,612,599		$	13,041,870	$	(996,859	)	$	4,417,511	$	(16,462,522	)	$	3,612,599
Unrealized loss on derivative instruments		—			—		(573,164	)		—		—			(573,164	)
Total comprehensive income (loss)	$	3,612,599		$	13,041,870	$	(1,570,023	)	$	4,417,511	$	(16,462,522	)	$	3,039,435

4

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Statement of Operations and Comprehensive Income

For the Six Months Ended June 30, 2013

(unaudited)

				Unencumbered Subsidiary			Encumbered Subsidiary			Non-Guarantor
	Issuers			Guarantors			Guarantors			Subsidiaries		Eliminations			Consolidated
Revenues
Rental income	$	—		$	49,567,192		$	14,564,994		$	3,381,460	$	—		$	67,513,646
Interest on secured loans and financing lease		573,800			1,403,393			163,921			—		—			2,141,114
Interest and other income		4,327			73,248			1,254			83		—			78,912
Total revenues		578,127			51,043,833			14,730,169			3,381,543		—			69,733,672
Expenses
Interest expense		16,015,717			—			6,215,373			496,963		—			22,728,053
Depreciation and amortization		2,688			12,356,055			2,894,532			844,189		—			16,097,464
General and administrative		12,320,541			110,572			4,937,596			63,692		—			17,432,401
Transaction costs		181,697			234,383			1,050			129,593		—			546,723
Reserve for uncollectible secured loan and other receivables		(9,594	)		(10,557	)		49,932			—		—			29,781
Gain on sale of assets, net		—			(39,177	)		—			—		—			(39,177	)
Loss on extinguishment of debt		—			—			10,974,196			—		—			10,974,196
Total expenses		28,511,049			12,651,276			25,072,679			1,534,437		—			67,769,441
(Loss) income from continuing operations		(27,932,922	)		38,392,557			(10,342,510	)		1,847,106		—			1,964,231
Discontinued operations		—			—			—			—		—			—
Net (loss) income		(27,932,922	)		38,392,557			(10,342,510	)		1,847,106		—			1,964,231
Equity in income (loss) of subsidiaries		29,897,153			—			—			—		(29,897,153	)		—
Net income (loss) allocable to units	$	1,964,231		$	38,392,557		$	(10,342,510	)	$	1,847,106	$	(29,897,153	)	$	1,964,231

5

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Statement of Operations and Comprehensive Income

For the Six Months Ended June 30, 2012

(unaudited)

				Unencumbered Subsidiary		Encumbered Subsidiary			Non-Guarantor
	Issuers			Guarantors		Guarantors			Subsidiaries		Eliminations			Consolidated
Revenues
Rental income	$	—		$	44,289,496	$	14,276,901		$	763,187	$	—		$	59,329,584
Interest on secured loans and financing lease		1,078,193			1,431,470		173,651			—		—			2,683,314
Interest and other income		3,283			64,721		307			—		—			68,311
Total revenues		1,081,476			45,785,687		14,450,859			763,187		—			62,081,209
Expenses
Interest expense		14,075,211			—		10,458,726			253,894		—			24,787,831
Depreciation and amortization		—			9,816,925		2,764,719			195,378		—			12,777,022
General and administrative		2,744,838			168,324		4,536,384			8,630		—			7,458,176
Transaction costs		1,010,295			985,460		188,957			35,920		—			2,220,632
Loss on impairment of assets		—			4,378,858		—			—		—			4,378,858
Reserve for uncollectible secured loan and other receivables		3,474,989			1,659,015		81,794			508		—			5,216,306
Other expenses		—			—		200,177			—		—			200,177
Total expenses		21,305,333			17,008,582		18,230,757			494,330		—			57,039,002
(Loss) income from continuing operations		(20,223,857	)		28,777,105		(3,779,898	)		268,857		—			5,042,207
Discontinued operations		—			331,589		—			4,255,104		—			4,586,693
Net (loss) income		(20,223,857	)		29,108,694		(3,779,898	)		4,523,961		—			9,628,900
Equity in income (loss) of subsidiaries		29,852,757			—		—			—		(29,852,757	)		—
Net income (loss) allocable to units	$	9,628,900		$	29,108,694	$	(3,779,898	)	$	4,523,961	$	(29,852,757	)	$	9,628,900
Unrealized loss on derivative instruments		—			—		(781,492	)		—		—			(781,492	)
Total comprehensive income (loss)	$	9,628,900		$	29,108,694	$	(4,561,390	)	$	4,523,961	$	(29,852,757	)	$	8,847,408

6

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Statement of Cash Flows

For the Six Months Ended June 30, 2013

(unaudited)

				Unencumbered Subsidiary			Encumbered Subsidiary			Non-Guarantor
	Issuers			Guarantors			Guarantors			Subsidiaries			Eliminations		Consolidated
Net cash (used in) provided by operating activities	$	(233,399,474	)	$	13,463,332		$	210,220,445		$	36,916,038		$	—	$	27,200,341
Investing activities
Purchase of real estate investments		—			—			—			(28,026,000	)		—		(28,026,000	)
Sale of real estate investments		—			2,605,597			—			—			—		2,605,597
Capital improvements		350			(6,951,522	)		(766,829	)		(198,115	)		—		(7,916,116	)
Development projects		—			(7,150,444	)		(50,777	)		(896,639	)		—		(8,097,860	)
Secured loan receivables received from others		1,580,334			604,180			176,011			—			—		2,360,525
Secured loan receivables funded to others		(369,864	)		(2,181,815	)		(155,704	)		—			—		(2,707,383	)
Net cash provided by (used in) investing activities		1,210,820			(13,074,004	)		(797,299	)		(29,120,754	)		—		(41,781,237	)
Financing activities
Borrowings of debt		—			—			145,000,000			—			—		145,000,000
Repayment of debt		—			—			(345,506,139	)		(7,658,818	)		—		(353,164,957	)
Payment of financing costs		—			—			(5,281,958	)		(975	)		—		(5,282,933	)
Payment for swap termination		—			—			(3,606,000	)		—			—		(3,606,000	)
Capital contributions		425,149			—			—			—			—		425,149
Initial public offering proceeds		303,600,000			—			—			—			—		303,600,000
Cost of raising capital		(25,387,224	)		—			—			—			—		(25,387,224	)
Cash distributions to partners		(47,517,803	)		—			—			—			—		(47,517,803	)
Net cash provided by (used in) financing activities		231,120,122			—			(209,394,097	)		(7,659,793	)		—		14,066,232
Net (decrease) increase in cash and cash equivalents		(1,068,532	)		389,328			29,049			135,491			—		(514,664	)
Cash and cash equivalents:
Beginning of period		16,869,495			(1,746,141	)		(68,241	)		479,260			—		15,534,373
End of period	$	15,800,963		$	(1,356,813	)	$	(39,192	)	$	614,751		$	—	$	15,019,709

7

Aviv Healthcare Properties Limited Partnership and Subsidiaries

Condensed Consolidating Statement of Cash Flows

For the Six Months Ended June 30, 2012

(unaudited)

	Issuers			Unencumbered Subsidiary Guarantors			Encumbered Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations		Consolidated
Net cash (used in) provided by operating activities	$	(148,522,190	)	$	105,464,686		$	67,229,677		$	(6,323,844	)	$	—	$	17,848,329
Investing activities
Purchase of real estate investments		—			(99,171,000	)		(4,800,000	)		(4,540,206	)		—		(108,511,206	)
Sale of real estate investments		—			13,806,873			—			16,735,771			—		30,542,644
Capital improvements		—			(3,562,065	)		(2,762,894	)		—			—		(6,324,959	)
Development projects		—			(12,891,186	)		—			(1,508,405	)		—		(14,399,591	)
Secured loan receivables received from others		2,571,657			850,381			281,971			—			—		3,704,009
Secured loan receivables funded to others		(2,163,720	)		(1,742,943	)		(28,660	)		—			—		(3,935,323	)
Net cash provided by (used in) investing activities		407,937			(102,709,940	)		(7,309,583	)		10,687,160			—		(98,924,426	)
Financing activities
Borrowings of debt		101,000,000			—			87,504,200			2,536,894			—		191,041,094
Repayment of debt		—			—			(145,100,212	)		(6,124,390	)		—		(151,224,602	)
Payment of financing costs		(2,539,196	)		—			(2,581,092	)		—			—		(5,120,288	)
Capital contributions		75,000,000			—			—			—			—		75,000,000
Deferred contribution		(35,000,000	)		—			—			—			—		(35,000,000	)
Cash distributions to partners		(22,220,232	)		—			—			—			—		(22,220,232	)
Net cash provided by (used in) financing activities		116,240,572			—			(60,177,104	)		(3,587,496	)		—		52,475,972
Net (decrease) increase in cash and cash equivalents		(31,873,681	)		2,754,746			(257,010	)		775,820			—		(28,600,125	)
Cash and cash equivalents:
Beginning of period		42,354,896			(2,874,571	)		242,153			(518,751	)		—		39,203,727
End of period	$	10,481,215		$	(119,825	)	$	(14,857	)	$	257,069		$	—	$	10,603,602

8